Healthcare Antitrust: New DOJ and FTC Merger Guidelines, Recent State Regulatory Changes

This CLE course will guide healthcare counsel on recent antitrust developments and their implications for the healthcare industry. The panel will discuss the recent draft Merger Guidelines and state regulatory changes. The panel will also review recent Department of Justice (DOJ) and Federal Trade Commission (FTC) litigation and offer best practices for ensuring antitrust compliance.

The healthcare industry has seen significant developments in healthcare antitrust over the past few years. Healthcare saw an unprecedented level of antitrust enforcement by both state and federal regulators. State regulators proposed new legislation that would impact the review of future healthcare transactions.

In July 2023, the DOJ and the FTC issued a draft of the new Merger Guidelines, which would replace the 2010 Horizontal Merger Guidelines and the 2020 Vertical Merger Guidelines. The new guidelines explain how the current DOJ and FTC review mergers and acquisitions and their compliance with federal antitrust laws.

Listen as our authoritative panel of healthcare attorneys examines recent developments impacting healthcare antitrust and the implications for healthcare providers and others in the healthcare industry. The panel will discuss the recent draft Merger Guidelines as well as state regulatory changes. The panel will also review recent DOJ and FTC litigation. The panel will offer best practices for ensuring antitrust compliance.